Profiling Tests May Predict Chemo Efficacy in Early-Stage Breast Cancer
December 8th 2023Future research may focus on the relationship between neoadjuvant chemotherapy regimens, pathologic complete response, and whole transcriptome changes in patients with hormone receptor–positive, HER2-negative early-stage breast cancer.